Gene · 2202
Papers1,739
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,739
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of aging-related gene signatures and their immune landscape in diabetic nephropathy. | Front Med (Lausanne) | 2023 | 37404805 | PubTator, text mining | PubMed |
| Circulating and non-circulating proteins and nucleic acids as biomarkers and therapeutic molecules in ovarian cancer. | Genes Dis | 2023 | 37396515 | PubTator, text mining | PubMed |
| Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp. | Cancers (Basel) | 2023 | 37370809 | PubTator, text mining | PubMed |
| Defining the ligand-dependent proximatome of the sigma 1 receptor. | Front Cell Dev Biol | 2023 | 37351276 | PubTator, text mining | PubMed |
| Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis. | Thorac Cancer | 2023 | 37340889 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals maturation of transplanted stem cell-derived retinal pigment epithelial cells toward native state. | Proc Natl Acad Sci U S A | 2023 | 37339216 | PubTator, text mining | PubMed |
| Identification of molecular mechanisms causing skin lesions of cutaneous leishmaniasis using weighted gene coexpression network analysis (WGCNA). | Sci Rep | 2023 | 37330553 | PubTator, text mining | PubMed |
| DiLeu Isobaric Labeling Coupled with Limited Proteolysis Mass Spectrometry for High-Throughput Profiling of Protein Structural Changes in Alzheimer's Disease. | Anal Chem | 2023 | 37307028 | PubTator, text mining | PubMed |
| How to Set Up Genetic Counselling for Inherited Macular Dystrophies: Focus on Genetic Characterization. | Int J Mol Sci | 2023 | 37298674 | PubTator, text mining | PubMed |
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study). | Discov Oncol | 2023 | 37278858 | PubTator, text mining | PubMed |
| Intercellular communication involving macrophages at the maternal-fetal interface may be a pivotal mechanism of URSA: a novel discovery from transcriptomic data. | Front Endocrinol (Lausanne) | 2023 | 37265689 | PubTator, text mining | PubMed |
| Association analysis and functional follow-up identified common variants of JAG1 accounting for risk to biliary atresia. | Front Genet | 2023 | 37255715 | PubTator, text mining | PubMed |
| Regulation of the Gene Expression of Airway MUC5AC Mucin through NF-κB Signaling Pathway by Artesunate, an Antimalarial Agent. | Biomol Ther (Seoul) | 2023 | 37254459 | PubTator, text mining | PubMed |
| METTL1 gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study. | Chin Med J (Engl) | 2023 | 37232474 | PubTator, text mining | PubMed |
| Mutations in EFEMP1 in Patients with Juvenile Open-Angle Glaucoma. | Ophthalmol Glaucoma | 2023 | 37224920 | PubTator, text mining | PubMed |
| GC-MS-based untargeted metabolic profiling of malignant mesothelioma plasma. | PeerJ | 2023 | 37220527 | PubTator, text mining | PubMed |
| A potential biological signature of 7-methylguanosine-related lncRNA to predict the immunotherapy effects in bladder cancer. | Heliyon | 2023 | 37215925 | PubTator, text mining | PubMed |
| Functional and Clinical Proteomic Exploration of Pancreatic Cancer. | Mol Cell Proteomics | 2023 | 37209817 | PubTator, text mining | PubMed |
| In-Depth Serum Proteomics Reveals the Trajectory of Hallmarks of Cancer in Hepatitis B Virus-Related Liver Diseases. | Mol Cell Proteomics | 2023 | 37209815 | PubTator, text mining | PubMed |
| Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers. | Front Immunol | 2023 | 37205098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2202/papers?page=12